|
1
|
Spiro SG and Silvestri GA: One hundred
years of lung cancer. Am J Respir Crit Care Med. 172:523–529. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Parkin DM, Bray F, Ferlay J and Pisani P:
Global cancer statistics. 2002 CA Cancer J Clin. 55:1–108.
2005.
|
|
3
|
Yang P, Allen MS, Aubry MC, Wampfler JA,
Marks RS, Edell ES, Thibodeau S, Adjei AA, Jett J and Deschamps C:
Clinical features of 5,628 primary lung cancer patients: Experience
at Mayo Clinic from 1997 to 2003. Chest. 128:452–462. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2012. CA Cancer J Clin. 62:10–29. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lee RC, Feinbaum RL and Ambros V: The C.
elegans heterochronic gene lin-4 encodes small RNAs with antisense
complementarity to lin-14. Cell. 75:843–854. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ortholan C, Puissegur MP, Ilie M, Barbry
P, Mari B and Hofman P: MicroRNAs and lung cancer: New oncogenes
and tumor suppressors, new prognostic factors and potential
therapeutic targets. Curr Med Chem. 16:1047–1061. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Salim H, Akbar NS, Zong D, Vaculova AH,
Lewensohn R, Moshfegh A, Viktorsson K and Zhivotovsky B: miRNA-214
modulates radiotherapy response of non-small cell lung cancer cells
through regulation of p38MAPK, apoptosis and senescence. Br J
Cancer. 107:1361–1373. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Oh JS, Kim JJ, Byun JY and Kim IA:
Lin28-let7 modulates radiosensitivity of human cancer cells with
activation of K-Ras. Int J Radiat Oncol Biol Phys. 76:5–8. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Liu S, Kumar SM, Lu H, Liu A, Yang R,
Pushparajan A, Guo W and Xu X: MicroRNA-9 up-regulates E-cadherin
through inhibition of NF-κB1-Snail1 pathway in melanoma. J Pathol.
226:61–72. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ma L, Young J, Prabhala H, Pan E, Mestdagh
P, Muth D, Teruya-Feldstein J, Reinhardt F, Onder TT, Valastyan S,
et al: miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin
and cancer metastasis. Nat Cell Biol. 12:247–256. 2010.PubMed/NCBI
|
|
12
|
Hu X, Schwarz JK, Lewis JS Jr, Huettner
PC, Rader JS, Deasy JO, Grigsby PW and Wang X: A microRNA
expression signature for cervical cancer prognosis. Cancer Res.
70:1441–1448. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Rodriguez-Otero P, Román-Gómez J,
Vilas-Zornoza A, José-Eneriz ES, Martín-Palanco V, Rifón J, Torres
A, Calasanz MJ, Agirre X and Prosper F: Deregulation of FGFR1 and
CDK6 oncogenic pathways in acute lymphoblastic leukaemia harbouring
epigenetic modifications of the MIR9 family. Br J Haematol.
155:73–83. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wild JR, Staton CA, Chapple K and Corfe
BM: Neuropilins: Expression and roles in the epithelium. Int J Exp
Pathol. 93:81–103. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Brieger J, Schroeder P, Gosepath J and
Mann WJ: VEGF-subtype specific protection of SCC and HUVECs from
radiation induced cell death. Int J Mol Med. 15:145–151.
2005.PubMed/NCBI
|
|
16
|
Glinka Y, Mohammed N, Subramaniam V, Jothy
S and Prud'homme GJ: Neuropilin-1 is expressed by breast cancer
stem-like cells and is linked to NF-κB activation and tumor sphere
formation. Biochem Biophys Res Commun. 425:775–780. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Dong JC, Gao H, Zuo SY, Zhang HQ, Zhao G,
Sun SL, Han HL, Jin LL, Shao LH, Wei W and Jin SZ: Neuropilin 1
expression correlates with the Radio-resistance of human
non-small-cell lung cancer cells. J Cell Mol Med. 19:2286–2295.
2015.PubMed/NCBI
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hershkovitz-Rokah O, Modai S,
Pasmanik-Chor M, Toren A, Shomron N, Raanani P, Shpilberg O and
Granot G: MiR-30e induces apoptosis and sensitizes K562 cells to
imatinib treatment via regulation of the BCR-ABL protein. Cancer
Lett. 356:597–605. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hong TM, Chen YL, Wu YY, Yuan A, Chao YC,
Chung YC, Wu MH, Yang SC, Pan SH, Shih JY, et al: Targeting
neuropilin 1 as an antitumor strategy in lung cancer. Clin Cancer
Res. 13:4759–4768. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Xu T, Liu X, Han L, Shen H, Liu L and Shu
Y: Up-regulation of miR-9 expression as a poor prognostic biomarker
in patients with non-small cell lung cancer. Clin Transl Oncol.
16:469–475. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wan HY, Guo LM, Liu T, Liu M, Li X and
Tang H: Regulation of the transcription factor NF-kappaB1 by
microRNA-9 in human gastric adenocarcinoma. Mol Cancer. 9:162010.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhu M, Xu Y, Ge M, Gui Z and Yan F:
Regulation of UHRF1 by microRNA-9 modulates colorectal cancer cell
proliferation and apoptosis. Cancer Sci. 106:833–839. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang H, Zhang W, Zuo Y, Ding M, Ke C, Yan
R, Zhan H, Liu J and Wang J: miR-9 promotes cell proliferation and
inhibits apoptosis by targeting LASS2 in bladder cancer. Tumour
Biol. 36:9631–9640. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhu SW, Li JP, Ma XL, Ma JX, Yang Y, Chen
Y and Liu W: miR-9 modulates osteosarcoma cell growth by targeting
the GCIP tumor suppressor. Asian Pac J Cancer Prev. 16:4509–4513.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chen P, Price C, Li Z, Li Y, Cao D, Wiley
A, He C, Gurbuxani S, Kunjamma RB, Huang H, et al: miR-9 is an
essential oncogenic microRNA specifically overexpressed in mixed
lineage leukemia-rearranged leukemia. Proc Natl Acad Sci USA.
110:pp. 11511–11516. 2013; View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhao HM, Wei W, Sun YH, Gao JH, Wang Q and
Zheng JH: MicroRNA-9 promotes tumorigenesis and mediates
sensitivity to cisplatin in primary epithelial ovarian cancer
cells. Tumour Biol. 36:6867–6873. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Guo LM, Pu Y, Han Z, Liu T, Li YX, Liu M,
Li X and Tang H: MicroRNA-9 inhibits ovarian cancer cell growth
through regulation of NF-kappaB1. FEBS J. 276:5537–5546. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang J, Yang B, Han L, Li X, Tao H, Zhang
S and Hu Y: Demethylation of miR-9-3 and miR-193a genes suppresses
proliferation and promotes apoptosis in non-small cell lung cancer
cell lines. Cell Physiol Biochem. 32:1707–1719. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Pawlik TM and Keyomarsi K: Role of cell
cycle in mediating sensitivity to radiotherapy. Int J Radiat Oncol
Biol Phys. 59:928–942. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Murga M, Fernandez-Capetillo O and Tosato
G: Neuropilin-1 regulates attachment in human endothelial cells
independently of vascular endothelial growth factor receptor-2.
Blood. 105:1992–1999. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kawakami T, Tokunaga T, Hatanaka H, Kijima
H, Yamazaki H, Abe Y, Osamura Y, Inoue H, Ueyama Y and Nakamura M:
Neuropilin 1 and neuropilin 2 co-expression is significantly
correlated with increased vascularity and poor prognosis in
nonsmall cell lung carcinoma. Cancer. 95:2196–2201. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yahyanejad S, Theys J and Vooijs M:
Targeting Notch to overcome radiation resistance. Oncotarget.
7:7610–7628. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhao L, Lu X and Cao Y: MicroRNA and
signal transduction pathways in tumor radiation response. Cell
Signal. 25:1625–1634. 2013. View Article : Google Scholar : PubMed/NCBI
|
